Abstract:
Purpose of the study: To evaluate the diagnostic value of an integrated multimarker strategy based
on NT-proBNP, PRO-C3, and cytokeratin-18 fragment (CK-18, M30) for non-invasive assessment of
liver fibrosis in patients with stage IIA HFpEF and concomitant MASLD